Release Date: 29/02/12 13:35 Summary: Bullabulling Resource Upgrade - Amended 29.02.12 Price Sensitive: No Download Document 1.36MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%